Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 119 results.
User Information
Export Records
  1. 1.   Development of a proficiency testing program for HPV serology assays used to evaluate antibody responses in vaccine trials
  2. Miller, Cheryl; Kemp,Troy; Pinto,Ligia
  3. Journal of Immunological Methods. 2023, Nov 08; 113585.
  1. 2.   Proteogenomic insights suggest druggable pathways in endometrial carcinoma
  2. Dou, Yongchao; Katsnelson, Lizabeth; Gritsenko, Marina A; Hu, Yingwei; Reva, Boris; Hong, Runyu; Wang, Yi-Ting; Kolodziejczak, Iga; Lu, Rita Jui-Hsien; Tsai, Chia-Feng; Bu, Wen; Liu, Wenke; Guo, Xiaofang; An, Eunkyung; Arend, Rebecca C; Bavarva, Jasmin; Chen, Lijun; Chu, Rosalie K; Czekanski, Andrzej; Davoli, Teresa; Demicco, Elizabeth G; DeLair, Deborah; Devereaux, Kelly; Dhanasekaran, Saravana M; Dottino, Peter; Dover, Bailee; Fillmore, Thomas L; Foxall, McKenzie; Hermann, Catherine E; Hiltke, Tara; Hostetter, Galen; Jedryka, Marcin; Jewell, Scott D; Johnson, Isabelle; Kahn, Andrea G; Ku, Amy T; Kumar-Sinha, Chandan; Kurzawa, Pawel; Lazar, Alexander J; Lazcano, Rossana; Lei, Jonathan T; Li, Yi; Liao, Yuxing; Lih, Tung-Shing M; Lin, Tai-Tu; Martignetti, John A; Masand, Ramya P; Matkowski, Rafal; McKerrow, Wilson; Mesri, Mehdi; Monroe, Matthew E; Moon, Jamie; Moore, Ronald J; Nestor, Michael D; Newton, Chelsea; Omelchenko, Tatiana; Omenn, Gilbert S; Payne, Samuel H; Petyuk, Vladislav A; Robles, Ana I; Rodriguez, Henry; Ruggles, Kelly V; Rykunov, Dmitry; Savage, Sara R; Schepmoes, Athena A; Shi, Tujin; Shi, Zhiao; Tan, Jimin; Taylor, Mason; Thiagarajan,Mathangi; Wang, Joshua M; Weitz, Karl K; Wen, Bo; Williams, C M; Wu, Yige; Wyczalkowski, Matthew A; Yi, Xinpei; Zhang, Xu; Zhao, Rui; Mutch, David; Chinnaiyan, Arul M; Smith, Richard D; Nesvizhskii, Alexey I; Wang, Pei; Wiznerowicz, Maciej; Ding, Li; Mani, D R; Zhang, Hui; Anderson, Matthew L; Rodland, Karin D; Zhang, Bing; Liu, Tao; Fenyö, David
  3. Cancer Cell. 2023, Sep 11; 41(9): 1586-1605.e15.
  1. 3.   Protocol for measuring BRAF autoinhibition in live cells using a proximity-based NanoBRET assay
  2. Smith,Russell; Morrison,Deborah
  3. STAR Protocols. 2023, Aug 16; 4(3): 102461.
  1. 4.   Cytokines: From Clinical Significance to Quantification
  2. Liu, Chao; Chu, Dewei; Kalantar-Zadeh, Kourosh; George, Jacob; Young,Howard; Liu, Guozhen
  3. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2021, Jun 10;
  1. 5.   HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus
  2. Halvas, Elias K; Joseph, Kevin W; Brandt, Leah D; Guo,Amber; Sobolewski, Michele D; Jacobs, Jana L; Tumiotto, Camille; Bui, John K; Cyktor, Joshua C; Keele,Brandon; Morse, Gene D; Bale, Michael J; Shao,Wei; Kearney,Mary; Coffin, John M; Rausch,Jason; Wu,Xiaolin; Hughes,Stephen; Mellors, John W
  3. The Journal of clinical investigation. 2020, NOV 2; 130(11): 5847-5857.
  1. 6.   LC-MS-sMRM method development and validation of different classes of pain panel drugs and analysis of clinical urine samples
  2. Masood, M Athar; Veenstra, Timothy D
  3. Basic & clinical pharmacology & toxicology. 2020, Nov 01;
  1. 7.   Calibration of pathogenicity due to variant-induced leaky splicing defects by using BRCA2 exon 3 as a model system
  2. Tubeuf, Hélène; Caputo, Sandrine M; Sullivan,Teresa; Rondeaux, Julie; Krieger, Sophie; Caux-Moncoutier, Virginie; Hauchard, Julie; Castelain, Gaia; Fiévet, Alice; Meulemans, Laëtitia; Révillion, Françoise; Léone, Mélanie; Boutry-Kryza, Nadia; Delnatte, Capucine; Guillaud-Bataille, Marine; Cleveland, Linda; Reid,Susan; Southon,Eileen; Soukarieh, Omar; Drouet, Aurélie; Di Giacomo, Daniela; Vezain, Myriam; Bonnet-Dorion, Françoise; Bourdon, Violaine; Larbre, Hélène; Muller, Danièle; Pujol, Pascal; Vaz, Fátima; Audebert-Bellanger, Séverine; Colas, Chrystelle; Venat-Bouvet, Laurence; Solano, Angela R; Stoppa-Lyonnet, Dominique; Houdayer, Claude; Frebourg, Thierry; Gaildrat, Pascaline; Sharan, Shyam K; Martins, Alexandra
  3. Cancer research. 2020, SEP 1; 80(17): 3593-3605.
  1. 8.   New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics
  2. Esposito,Dom; Stephen,Andy; Turbyville,Tommy; Holderfield, Matthew
  3. Seminars in Cancer Biology. 2019, Feb; 54: 174-182.
  1. 9.   Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
  2. Pinto, Ligia; Dillner, Joakim; Beddows, Simon; Unger, Elizabeth R
  3. Vaccine. 2018, Aug 06; 36(32 Pt. A): 4792-4799.
  1. 10.   Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1)
  2. Bermingham, Alun; Price, Edmund; Marchand, Christophe; Chergui, Adel; Naumova, Alena; Whitson, Emily L; Haugh Krumpe, Lauren; Goncharova, Katya; Evans, Jason; McKee, Tawnya; Henrich, Curtis; Pommier, Yves; O'Keefe, Barry
  3. SLAS discovery. 2017, Oct; 22(9): 1093-1105.
  1. 11.   LC-MS-sMRM Method Development and Validation of Different Classes of Pain Panel Drugs and Analysis of Clinical Urine Samples
  2. Athar Masood, M; Veenstra, Timothy D
  3. Basic & Clinical Pharmacology & Toxicology. 2017, Aug 26;
  1. 12.   High-throughput single-molecule screen for small-molecule perturbation of splicing and transcription kinetics
  2. Day, C. R.; Chen, H.; Coulon, A.; Meier, J. L.; Larson, D. R.
  3. Methods (San Diego, Calif.). 2016, 1-Mar; 96: 59-68.
  1. 13.   Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies
  2. Wang, J. W.; Matsui, K.; Pan, Y.; Kwak, K.; Peng, S.; Kemp, T.; Pinto, L.; Roden, R. B.
  3. Current protocols in microbiology. 2015 38: 14B 5 1-26.
  1. 14.   Analytical characterization of ch14.18 A mouse-human chimeric disialoganglioside-specific therapeutic antibody
  2. Soman, G.; Kallarakal, A. T.; Michiel, D.; Yang, X. Y.; Saptharishi, N.; Jiang, H. G.; Giardina, S.; Gilly, J.; Mitra, G.
  3. Mabs. 2012, Jan-Feb; 4(1): 84-100.
  1. 15.   Targeted mass spectrometry approaches for protein biomarker verification
  2. Meng, Z. J.; Veenstra, T. D.
  3. Journal of Proteomics. 2011, Nov; 74(12): 2650-2659.
  1. 16.   Evaluation of Multiplexed Cytokine and Inflammation Marker Measurements: a Methodologic Study
  2. Chaturvedi, A. K.; Kemp, T. J.; Pfeiffer, R. M.; Biancotto, A.; Williams, M.; Munuo, S.; Purdue, M. P.; Hsing, A. W.; Pinto, L.; McCoy, J. P.; Hildesheim, A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2011, Sep; 20(9): 1902-1911.
  1. 17.   A Dual-Readout F(2) Assay That Combines Fluorescence Resonance Energy Transfer and Fluorescence Polarization for Monitoring Bimolecular Interactions
  2. Du, Y. H.; Nikolovska-Coleska, Z.; Qui, M.; Li, L.; Lewis, I.; Dingledine, R.; Stuckey, J. A.; Krajewski, K.; Roller, P. P.; Wang, S. M.; Fu, H. A.
  3. Assay and Drug Development Technologies. 2011, Aug; 9(4): 382-393.
  1. 18.   Carminomycin I Is an Apoptosis Inducer That Targets the Golgi Complex in Clear Cell Renal Carcinoma Cells
  2. Woldemichael, G. M.; Turbyville, T. J.; Linehan, W. M.; McMahon, J. B.
  3. Cancer Research. 2011, Jan; 71(1): 134-142.
  1. 19.   Multiplex cytokine analysis technologies
  2. Lash, G. E.; Pinto, L. A.
  3. Expert Review of Vaccines. 2010, Oct; 9(10): 1231-1237.
  1. 20.   In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines
  2. Behrsing, H. P.; Furniss, M. J.; Robillard, K. A.; Tomaszewski, J. E.; Parchment, R. E.
  3. Cancer Chemotherapy and Pharmacology. 2010, May; 65(6): 1083-1091.
  1. 21.   Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome
  2. Jang, H.; Arce, F. T.; Ramachandran, S.; Capone, R.; Azimova, R.; Kagan, B. L.; Nussinov, R.; Lal, R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Apr; 107(14): 6538-6543.
  1. 22.   Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: A new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA
  2. Mbisa, G. L.; Miley, W.; Gamache, C. J.; Gillette, W. K.; Esposito, D.; Hopkins, R.; Busch, M. P.; Schreiber, G. B.; Little, R. F.; Yarchoan, R.; Ortiz-Conde, B. A.; Labo, N.; Whitby, D.
  3. Journal of Immunological Methods. 2010, Apr; 356(1-2): 39-46.
  1. 23.   Comparison of mRNA and Protein Measures of Cytokines following Vaccination with Human Papillomavirus-16 L1 Virus-like Particles
  2. Shebl, F. M.; Pinto, L. A.; Garcia-Pineres, A.; Lempicki, R.; Williams, M.; Harro, C.; Hildesheim, A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2010, Apr; 19(4): 978-981.
  1. 24.   Host genes associated with HIV/AIDS: advances in gene discovery
  2. An, P.; Winkler, C. A.
  3. Trends in Genetics. 2010, Mar; 26(3): 119-131.
  1. 25.   Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii
  2. Klausmeyer, P.; Zhou, Q.; Scudiero, D. A.; Uranchimeg, B.; Melillo, G.; Cardellina, J. H.; Shoemaker, R. H.; Chang, C. J.; McCloud, T. G.
  3. Journal of Natural Products. 2009, May 22; 72(5): 805-12.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel